Company / Free Cash Flow per Share
Terns Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.88
FY2024
5-year range
-$106.58 / -$0.88
FY2020-FY2024
Trend
+6.9%
vs FY2023
Sector context
#97 of 191
Health Care
What the data says
At $-0.88, Terns Pharmaceuticals, Inc.'s free cash flow per share ranks #97 of 191 in the Health Care sector. Free Cash Flow per Share has increased for 4 consecutive years, from $-106.58 in FY2020 to $-0.88 in FY2024.
Based on SEC 10-K filings.
-0.88 in FY2024.
Improved from $-1.37 to $-0.88 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#97 of 191 in Health CareTop 51% of 191This company -$0.88 Sector average -$24.68
▼
+96.4% above sector average
Key checks
Key Insights
- Terns Pharmaceuticals, Inc.'s free cash flow per share has grown for 4 consecutive years.
- In FY2024, free cash flow per share increased 6.9% year-over-year.
- Ranks #97 out of 191 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 7.86 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.88 | +6.9% |
| FY2023 | -$0.95 | +30.9% |
| FY2022 | -$1.37 | +26.2% |
| FY2021 | -$1.86 | +98.3% |
| FY2020 | -$106.58 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026